| Back To Health Physical Therapy Associates, P.a. | |
|
316 Maitland Ave, Teaneck, NJ 07666-3025 | |
| (201) 833-0234 | |
| Not Available |
| Full Name | Back To Health Physical Therapy Associates, P.a. |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 316 Maitland Ave, Teaneck, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174712178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 40QA01108500 (New Jersey) | Primary |
| Provider Name | Nezyl Adolfo Sindiong |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356377063 PECOS PAC ID: 6608817150 Enrollment ID: I20050516000487 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Mitchell E Simpson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1346346293 PECOS PAC ID: 2264464049 Enrollment ID: I20050927000967 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Stephanie L Spada |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124062278 PECOS PAC ID: 8729090006 Enrollment ID: I20060802000230 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Nancy C Buckholz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1104841154 PECOS PAC ID: 9032113618 Enrollment ID: I20060913000339 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Rebecca L Keenan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396842266 PECOS PAC ID: 8628086089 Enrollment ID: I20061211000135 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Patricia U Verdote |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124178991 PECOS PAC ID: 5193827491 Enrollment ID: I20070216000205 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Suzanne Wagner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1154490167 PECOS PAC ID: 8921065657 Enrollment ID: I20070409000560 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Elvira J Nafpliotis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720034366 PECOS PAC ID: 9335219740 Enrollment ID: I20080528000216 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Jill S Kaye |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1942234471 PECOS PAC ID: 2062459431 Enrollment ID: I20080725000037 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Luis R Lopez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1679720288 PECOS PAC ID: 1254492242 Enrollment ID: I20081209000681 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Deborah A Baum |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396072203 PECOS PAC ID: 9133254253 Enrollment ID: I20100315000826 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Jodi A Mclean |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1487962148 PECOS PAC ID: 7810176088 Enrollment ID: I20110120000971 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Megan Brooks |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1841520616 PECOS PAC ID: 9739222449 Enrollment ID: I20130404000299 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Urvish Barot |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1215292040 PECOS PAC ID: 1456587278 Enrollment ID: I20131126000578 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Susan G Feuerstein |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386048106 PECOS PAC ID: 3971826181 Enrollment ID: I20141219000471 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Diane Hennion |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740500719 PECOS PAC ID: 7517282692 Enrollment ID: I20150212000712 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Maria T Trevisani |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1659660728 PECOS PAC ID: 0648580720 Enrollment ID: I20151102000522 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Kimberly Estrada |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255702866 PECOS PAC ID: 6305156381 Enrollment ID: I20151103001446 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Maria Porta Oramas |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023479300 PECOS PAC ID: 1254638745 Enrollment ID: I20160329000615 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Tara Chedester |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417179672 PECOS PAC ID: 8820383979 Enrollment ID: I20160829000749 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Ileana M Toledo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588117261 PECOS PAC ID: 3577851542 Enrollment ID: I20161006000504 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Christine M Waryha |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407189053 PECOS PAC ID: 3870871312 Enrollment ID: I20161103000894 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Melissa D Stawinski |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275819930 PECOS PAC ID: 1153605985 Enrollment ID: I20170223000225 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Nicholas V Carrico |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1730636044 PECOS PAC ID: 0840574190 Enrollment ID: I20170304000176 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Anitha S Samuel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033533518 PECOS PAC ID: 2365668951 Enrollment ID: I20170612001510 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Jill M Chroback |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1790288249 PECOS PAC ID: 4284996281 Enrollment ID: I20180402000711 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Ari Rosen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1679971204 PECOS PAC ID: 7810246386 Enrollment ID: I20180816000182 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Jason Park |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376178731 PECOS PAC ID: 1557772712 Enrollment ID: I20201119003445 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Helen M Kim |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023297298 PECOS PAC ID: 7416038179 Enrollment ID: I20201216000534 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Rachel Y Rhodes |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770166431 PECOS PAC ID: 2769881366 Enrollment ID: I20210602001735 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Jenna M D'elio |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1497428502 PECOS PAC ID: 0446649677 Enrollment ID: I20211122002484 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Joan Whittaker |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1821745308 PECOS PAC ID: 9638556541 Enrollment ID: I20220516001144 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Alexandra M Alvarez |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376234344 PECOS PAC ID: 1951769694 Enrollment ID: I20230628000592 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Sophie S Buchbinder |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407549090 PECOS PAC ID: 1850759598 Enrollment ID: I20230628000613 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Provider Name | Talia Bachrach |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609257146 PECOS PAC ID: 8426363086 Enrollment ID: I20230718000269 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Back To Health Physical Therapy Associates, P.a. 316 Maitland Ave, Teaneck, NJ 07666-3025 Ph: (201) 833-0234 | Back To Health Physical Therapy Associates, P.a. 316 Maitland Ave, Teaneck, NJ 07666-3025 Ph: (201) 833-0234 |
News Archive
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
The heat of summer brings trips to the lake, afternoons at the beach and vacations in the mountains. It also arrives with the threat of dangerous conditions in closed cars, where children left alone for even a few minutes can lead to tragedy. Now, a team of researchers at the University of Georgia has developed an easy-to-use table of vehicle temperature changes that may help public officials and media remind the public about the deadly consequences of vehicle-related hyperthermia in children.
Horizon Pharma, Inc., a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and inflammation, today announced that its New Drug Application (NDA) for DUEXA®, a proprietary tablet formulation containing a fixed-dose combination of ibuprofen and high-dose famotidine, was accepted by the U.S. Food and Drug Administration (FDA) for review.
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
› Verified 3 days ago
Dr. Bryan Munoz, PT, DPT, CSCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 646 Kent Ave, Teaneck, NJ 07666 Phone: 201-692-1727 | |
Erin Davis, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3000 | |
Rena Rebecca Shulman, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 632 Norfolk St, Teaneck, NJ 07666 Phone: 201-836-8221 | |
Sara Kohanim, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 51 Grayson Pl, Teaneck, NJ 07666 Phone: 718-840-7835 | |
Kristen Sullivan, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3000 | |
Br3 Health & Performance L.l.c. Physical Therapist Medicare: Medicare Enrolled Practice Location: 646 Kent Ave, Teaneck, NJ 07666 Phone: 404-824-7617 | |
Sherein Abdelhady, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1086 Teaneck Rd # 3, Teaneck, NJ 07666 Phone: 201-833-1333 |